The U.S. Department of Justice (DOJ) announced on Wednesday the filing of a lawsuit against CVS Health Corporation, accusing the pharmacy chain of filling illegal opioid prescriptions and billing federal health insurance programs. This alleged misconduct is said to have significantly contributed to the ongoing opioid addiction crisis and rising overdose rates across the nation.
The unsealed complaint, filed in federal court in Providence, Rhode Island, claims that from October 2013 to the present, CVS violated the federal Controlled Substances Act by dispensing dangerous quantities of opioids and combining them with other harmful drugs without legitimate medical justification.
According to the DOJ, CVS routinely filled prescriptions from physicians operating “pill mills,” which are known for issuing large quantities of opioids without proper medical oversight. The lawsuit alleges that CVS’s corporate policies prioritized performance metrics over patient safety, leading to ignored red flags and, tragically, in some cases, patient overdoses shortly after receiving these prescriptions.
In response to the allegations, CVS stated, “We have cooperated with the DOJ’s investigation for more than four years and strongly disagree with the allegations and false narrative within this complaint.”
This lawsuit follows a previous settlement in 2022, where CVS agreed to pay nearly $5 billion over ten years to resolve thousands of similar claims from state and local governments as well as Native American tribes. Notably, CVS did not admit any wrongdoing as part of that agreement, which was part of a broader series of settlements totaling approximately $46 billion involving pharmacies, drug manufacturers, and distributors.
The DOJ’s lawsuit originated from a whistleblower complaint filed by a former CVS employee. The complaint highlights serious staffing deficiencies within CVS pharmacies and alleges that pharmacists were pressured to fill prescriptions rapidly without adequately verifying their legitimacy. One employee reportedly described the environment as akin to “an assembly-line style of medication preparation,” emphasizing that profit motives overshadowed patient safety.
The complaint further details alarming instances where CVS continued to fill prescriptions for a doctor in Alabama despite internal warnings about his investigation and filled thousands of prescriptions for another Pennsylvania doctor who allegedly prescribed opioids without proper patient evaluations.
Tragically, the complaint identifies ten individual patients who died after receiving illegal prescriptions for opioids and other medications at CVS locations. The opioid epidemic has claimed over 800,000 lives in the United States from 1999 through 2023, according to data from the U.S. Centers for Disease Control and Prevention (CDC), although preliminary data indicates a potential decline in overdose rates last year.
As this case unfolds, it underscores the critical need for accountability within pharmaceutical practices and highlights ongoing concerns regarding opioid prescribing standards in America.
Read more:
Law Firms Request $515 Million In Fees Following Historic NCAA Settlement
Congress Boosts Security Funding For Supreme Court Justices Amid Rising Threats
FTC Sues Southern Glazer’S Over Price Discrimination In Liquor Sales